Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 2

Status

Completed 4Unknown 1

Sponsor Class

OTHER 2NIH 2NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 5

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 32Leukemia 28Lymphoma 10Burkitt Lymphoma 9Leukemia, Promyelocytic, Acute 5Leukemia, Biphenotypic, Acute 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Acute 2Down Syndrome 2Dendritic Cell Sarcoma, Interdigitating 2Neoplasm, Residual 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Erythroblastic, Acute 1Drug-Related Side Effects and Adverse Reactions 1Childhood Acute Promyelocytic Leukemia With PML-RARA 1Cardiotoxicity 1Blast Crisis 1

Interventions

Tretinoin 12Arsenic Trioxide 7Methotrexate 5Mercaptopurine 5Cytarabine 5Idarubicin 4Mitoxantrone 3Thioguanine 2Radiotherapy 2Etoposide 2Daunorubicin 2Cyclophosphamide 2sargramostim 1merphos 1flt3 ligand protein 1Peripheral Blood Stem Cell Transplantation 1Maintenance 1Hydroxyurea 1Filgrastim 1Busulfan 1Amsacrine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Promyelocytic, Acute × Mercaptopurine × Clear all
NCT02688140 2026-05-29

TUD-APOLLO-064

Technische Universität Dresden

Phase 3 Completed
133 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT00492856 2023-01-10

S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia

SWOG Cancer Research Network

Phase 3 Completed
105 enrolled 7 charts
Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

NCT00482833 2022-10-12

APL0406

Gruppo Italiano Malattie EMatologiche dell'Adulto

Phase 3 Completed
276 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

NCT00002701 2013-09-20

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
750 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

NCT00003934 2013-06-05

Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia

National Cancer Institute (NCI)

Phase 3 Completed
420 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡